Skip to main content
letter
. 2020 Jul 5;10(3):e121. doi: 10.1002/ctm2.121

FIGURE 1.

FIGURE 1

A, Flow diagram of two independent CRLM patients enrolled from Zhongshan Hospital (MDT cohort and No‐MDT cohort); B, Kaplan‐Meier OS curves for CRLM patients of MDT and No‐MDT cohorts; C, Kaplan‐Meier OS curves for low CRS patients of MDT and No‐MDT cohorts; D, Kaplan‐Meier OS curves for high CRS patients MDT and No‐MDT cohorts; E, Kaplan‐Meier OS curves for low CRS patients with extra‐hepatic metastasis of MDT and No‐MDT cohorts; F, Kaplan‐Meier OS curves for low CRS patients without extra‐hepatic metastasis of MDT and No‐MDT cohorts, P‐values were determined by the log‐rank test. Abbreviations: CRLM, colorectal cancer liver metastasis; OS, overall survival; MDT, multi‐disciplinary treatment; CRLM, colorectal cancer liver metastasis; CRS, clinical risk score